BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7883730)

  • 1. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.
    Brady KT; Sonne SC; Anton R; Ballenger JC
    J Clin Psychiatry; 1995 Mar; 56(3):118-21. PubMed ID: 7883730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone in the treatment of mania.
    Tohen M; Zarate CA; Centorrino F; Hegarty JI; Froeschl M; Zarate SB
    J Clin Psychiatry; 1996 Jun; 57(6):249-53. PubMed ID: 8666562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of oral loading of divalproex sodium in the treatment of acute mania.
    Martinez JM; Russell JM; Hirschfeld RM
    Depress Anxiety; 1998; 7(2):83-6. PubMed ID: 9614597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between substance abuse and bipolar disorder.
    Brady KT; Sonne SC
    J Clin Psychiatry; 1995; 56 Suppl 3():19-24. PubMed ID: 7883738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
    Pavuluri MN; Henry DB; Carbray JA; Naylor MW; Janicak PG
    Bipolar Disord; 2005 Jun; 7(3):266-73. PubMed ID: 15898964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divalproex sodium treatment in late adolescent and young adult acute mania.
    Papatheodorou G; Kutcher SP
    Psychopharmacol Bull; 1993; 29(2):213-9. PubMed ID: 8290668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of valproate in primary psychiatric disorders.
    Hayes SG
    J Clin Psychiatry; 1989 Mar; 50 Suppl():35-9. PubMed ID: 2494158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open trial of valproate in borderline personality disorder.
    Stein DJ; Simeon D; Frenkel M; Islam MN; Hollander E
    J Clin Psychiatry; 1995 Nov; 56(11):506-10. PubMed ID: 7592502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A history of substance abuse complicates remission from acute mania in bipolar disorder.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1999 Nov; 60(11):733-40. PubMed ID: 10584760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
    Nolen WA; Luckenbaugh DA; Altshuler LL; Suppes T; McElroy SL; Frye MA; Kupka RW; Keck PE; Leverich GS; Post RM
    Am J Psychiatry; 2004 Aug; 161(8):1447-54. PubMed ID: 15285972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone for the treatment of depression: a preliminary report.
    Arana GW; Forbes RA
    J Clin Psychiatry; 1991 Jul; 52(7):304-6. PubMed ID: 2071561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine in patients with bipolar disorder and cocaine dependence.
    Brown ES; Nejtek VA; Perantie DC; Orsulak PJ; Bobadilla L
    J Clin Psychiatry; 2003 Feb; 64(2):197-201. PubMed ID: 12633129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance abuse and bipolar affective disorder.
    Sonne SC; Brady KT; Morton WA
    J Nerv Ment Dis; 1994 Jun; 182(6):349-52. PubMed ID: 8201307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness, safety and practicality of delayed-release minitablets of valproate in bipolar affective disorders].
    Grunze H; Amann B; Schäfer M; Sterr A; Schaerer L; Wild E; Walden J
    Fortschr Neurol Psychiatr; 2000 Nov; 68(11):496-502. PubMed ID: 11144934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate in psychiatric disorders: literature review and clinical guidelines.
    McElroy SL; Keck PE; Pope HG; Hudson JI
    J Clin Psychiatry; 1989 Mar; 50 Suppl():23-9. PubMed ID: 2494155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of sodium valproate as an anti-manic agent.
    Prasad AJ
    Pharmatherapeutica; 1984; 4(1):6-8. PubMed ID: 6438650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.